FPAS
Focus Partners Advisor Solutions’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $917K | Sell |
2,259
-2,828
| -56% | -$1.15M | 0.01% | 471 |
|
|
2025
Q1 | $2.53M | Buy |
5,087
+504
| +11% | +$251K | 0.04% | 222 |
|
|
2024
Q4 | $2.38M | Buy |
4,583
+2,548
| +125% | +$1.33M | 0.04% | 204 |
|
|
2024
Q3 | $1.26M | Buy |
2,035
+290
| +17% | +$180K | 0.03% | 258 |
|
|
2024
Q2 | $965K | Sell |
1,745
-2,701
| -61% | -$1.49M | 0.03% | 254 |
|
|
2024
Q1 | $2.58M | Buy |
4,446
+3,548
| +395% | +$2.06M | 0.07% | 134 |
|
|
2023
Q4 | $477K | Sell |
898
-1
| -0.1% | -$531 | 0.02% | 259 |
|
|
2023
Q3 | $456K | Buy |
899
+198
| +28% | +$100K | 0.02% | 277 |
|
|
2023
Q2 | $366K | Sell |
701
-90
| -11% | -$47K | 0.02% | 262 |
|
|
2023
Q1 | $457K | Sell |
791
-59
| -7% | -$34.1K | 0.03% | 213 |
|
|
2022
Q4 | $469K | Sell |
850
-389
| -31% | -$214K | 0.04% | 200 |
|
|
2022
Q3 | $628K | Buy |
1,239
+458
| +59% | +$232K | 0.04% | 192 |
|
|
2022
Q2 | $424K | Buy |
781
+272
| +53% | +$148K | 0.04% | 207 |
|
|
2022
Q1 | $301K | Buy |
+509
| New | +$301K | 0.03% | 240 |
|